SG Americas Securities’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-89,023
Closed -$171K 2516
2025
Q1
$171K Sell
89,023
-27,748
-24% -$53.3K ﹤0.01% 2357
2024
Q4
$222K Buy
116,771
+44,806
+62% +$85.2K ﹤0.01% 1812
2024
Q3
$95K Buy
71,965
+38,821
+117% +$51.2K ﹤0.01% 2753
2024
Q2
$34K Buy
+33,144
New +$34K ﹤0.01% 2349
2022
Q1
Sell
-43,176
Closed -$98K 2553
2021
Q4
$98K Sell
43,176
-68,084
-61% -$155K ﹤0.01% 2790
2021
Q3
$320K Buy
111,260
+98,423
+767% +$283K ﹤0.01% 2647
2021
Q2
$49K Sell
12,837
-18,080
-58% -$69K ﹤0.01% 2459
2021
Q1
$105K Buy
30,917
+12,421
+67% +$42.2K ﹤0.01% 2783
2020
Q4
$52K Sell
18,496
-214,366
-92% -$603K ﹤0.01% 2737
2020
Q3
$584K Buy
232,862
+178,717
+330% +$448K ﹤0.01% 1277
2020
Q2
$735K Buy
54,145
+19,275
+55% +$262K 0.01% 1458
2020
Q1
$264K Buy
34,870
+9,734
+39% +$73.7K ﹤0.01% 1941
2019
Q4
$159K Buy
25,136
+10,674
+74% +$67.5K ﹤0.01% 2280
2019
Q3
$57K Buy
+14,462
New +$57K ﹤0.01% 2377
2019
Q2
Sell
-26,797
Closed -$219K 2518
2019
Q1
$219K Sell
26,797
-52,227
-66% -$427K ﹤0.01% 2189
2018
Q4
$437K Sell
79,024
-605
-0.8% -$3.35K ﹤0.01% 1677
2018
Q3
$703K Buy
+79,629
New +$703K 0.01% 1731
2017
Q4
Sell
-8,650
Closed -$170K 2514
2017
Q3
$170K Sell
8,650
-534
-6% -$10.5K ﹤0.01% 2370
2017
Q2
$132K Buy
+9,184
New +$132K ﹤0.01% 2379
2017
Q1
Sell
-14,852
Closed -$155K 2774
2016
Q4
$155K Buy
+14,852
New +$155K ﹤0.01% 2249
2016
Q2
Sell
-10,096
Closed -$91K 2112
2016
Q1
$91K Buy
+10,096
New +$91K ﹤0.01% 2322